Previous 10 | Next 10 |
Xcelerate ( OTCQB:XCRT ) to acquire a controlling interest in ESN Group and its' portfolio of health care and skin care products. The companies have begun a 60-day period of due diligence and negotiation and preparation of definitive transaction agreements. ESN Group currently o...
Xcelerate, Inc. Executes Letter of Intent to Acquire a Controlling Interest in ESN, Inc. MAULDIN, SC / ACCESSWIRE / January 17, 2023 / Xcelerate, Inc. (OTCQB:XCRT) announced today that it had entered into a letter of intent to acquire a controlling interest in ESN Group, Inc. and its' por...
MAULDIN, SC / ACCESSWIRE / January 3, 2023 / Xcelerate, Inc. 's (OTCQB:"XCRT") Mike O'Shea, CEO, today released this letter and shareholder update. I would like to first thank our shareholders for their continued support throughout 2022 and wish all a healthy and prosperous New Year. 2022 ...
Xcelerate, Inc. to Develop Consumer Healthcare Products Based on Its Current Patent Portfolio MAULDIN, SC / ACCESSWIRE / August 30, 2022 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it had begun an initiative to identify marketing/manufacturing partners to assist in the devel...
MAULDIN, SC / ACCESSWIRE / August 23, 2022 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has received patent protection in nine additional countries. Korean Claim - In April 2022 our Korean Application, #10-2019-7006227, was allowed by the Korean Intellectual Property Office. ...
MAULDIN, SC / ACCESSWIRE / August 1, 2022 / Xcelerate, Inc. (OTCQB:XCRT), today announces that the OTC Market Group has approved the Company's application for uplisting to the OTCQB® Venture Market (the "OTCQB"). The Company will commence trading on the OTCQB with the market open ...
MAULDIN, SC / ACCESSWIRE / June 22, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it has initiated its plan to upgrade the trading of its common stock from the OTC Pink Market to the OTCQB Venture Market. The Company has submitted OTCQB application materials to OTC Markets ...
MAULDIN, SC / ACCESSWIRE / June 7, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that Cathy Scangarella has accepted an invitation to join its Advisory Board effective immediately. Cathy Scangarella is the Chief Business Development Officer and sector lead for Life Sciences at ...
AUSTIN, Texas, May 23, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Pink: XCRT, “Xcelerate” or “The Company”), and Jon Wilken, president...
MAULDIN, SC / ACCESSWIRE / May 11, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) recently announced that it had signed a purchase agreement to acquire a portfolio of patents, patents pending and technology licenses from HS Pharmaceuticals LLC, a company engaged in oncology research and the developm...
News, Short Squeeze, Breakout and More Instantly...
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2024) - InvestmentPirch Media video features Xcelerate, Inc. (OTCQB: XCRT), a holding company that is unique in that it was designed from inception to span the divide between initial non-medical engineering advancements and apply them to the...
MAULDIN, SC / ACCESSWIRE / June 6, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that they have retained Craft Capital Management, LLC ("Craft Capital") to provide investment banking services, help in facilitating a capital raise and other advisory services. Craft Capital, based in Gar...
MAULDIN, SC / ACCESSWIRE / June 4, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has become aware of an independent research report released by Harbinger Research earlier in the day that contains erroneous information about the Company and has reached out to the author of the r...